Comparative effectiveness research — the missing link in evidence‐informed clinical medicine and health care policy making

2013 ◽  
Vol 198 (6) ◽  
pp. 310-312 ◽  
Author(s):  
Ian A Scott
Keyword(s):  
Health Care ◽  
Comparative Effectiveness Research ◽  
Comparative Effectiveness ◽  
Policy Making ◽  
Health Care Policy ◽  
Clinical Medicine ◽  
Effectiveness Research ◽  
Care Policy ◽  
Missing Link

scholarly journals US Payer Perspectives on Evidence for Formulary Decision Making

2012 ◽  
Vol 8 (3S) ◽  
pp. 22s-27s ◽  
Author(s):  
Anthony Wang ◽  
Ronald J. Halbert ◽  
Tiffany Baerwaldt ◽  
Robert J. Nordyke
Keyword(s):  
Health Care ◽  
Decision Making ◽  
Comparative Effectiveness ◽  
Health Care Policy ◽  
Treatment Guidelines ◽  
Effectiveness Research ◽  
Care Policy ◽  
Policy Makers ◽  
Formulary Design ◽  
Effective Health Care

To improve formulary design processes and support payers in providing more effective health care, policy makers should consider involving commercial payers in the development of comparative effectiveness research and creation of research and treatment guidelines.

Randomized Controlled Trials and Comparative Effectiveness Research

2012 ◽  
Vol 30 (34) ◽  
pp. 4194-4201 ◽  
Author(s):  
Olwen M. Hahn ◽  
Richard L. Schilsky
Keyword(s):  
Health Care ◽  
Randomized Controlled Trials ◽  
Comparative Effectiveness Research ◽  
Comparative Effectiveness ◽  
Cost Effective ◽  
Health Care Research ◽  
Controlled Trials ◽  
Effectiveness Research ◽  
Randomized Controlled

Comparative effectiveness research (CER) has been promoted as a way to improve the translation gap between clinical research and everyday clinical practice as well as to deliver more cost-effective health care. CER will account for a significant portion of funding allocated by the US government for health care research. Oncology has a rich history of improving clinical outcomes and advancing research through randomized controlled trials (RCTs). In this article, we review the role of RCTs in achieving the goals of CER, with particular emphasis on the role of publicly funded clinical trials.

Comparative effectiveness research: policy and politics

2012 ◽  
Vol 33 (1) ◽  
pp. E6 ◽  
Author(s):  
Edie E. Zusman
Keyword(s):  
Health Care ◽  
Health Care Providers ◽  
Comparative Effectiveness Research ◽  
Comparative Effectiveness ◽  
Research Policy ◽  
Effectiveness Research ◽  
Care Providers ◽  
Future Health ◽  
The Future ◽  
Key Aspects

Comparative effectiveness research (CER) is the basis for some of the fiercest rhetoric of the current political era. While it is a relatively old and previously academic pursuit, CER may well become the foundation upon which the future of health care in the US is based. The actual impact of CER on—and uptake among—doctors, patients, hospitals, and health insurers, however, remains to be seen. Political considerations and compromises have led to the removal of key aspects of CER implementation from policy legislation to prevent alienating stakeholders critical to the success of health care reform. Health care providers, including specialists such as neurosurgeons, will need to understand both the policies and political implications of CER as its practices becomes an indelible part of the future health care landscape.

Sign in / Sign up

Export Citation Format

Share Document